Event Timing: April 7th, 2022 from 3:00 - 4:30
Location: Virtual - Via Zoom Link sent by Paul Huiras the morning of the event 04/07/22
Non-ACPE CE is provided via MSHP Heartland through the MN BOP
Presented by:

Melissa Perkins, PharmD – PGY1 – Essentia Health – St. Joseph’s Medical Center
Katie Sheetz, PharmD – PGY1 – Essentia Health – St. Joseph’s Medical Center
Hailey Haugen, PharmD – PGY1 – U of M– St. Cloud Centracare
Abigail Sirek, PharmD – PGY1 – U of M – Paynesville CentraCare
Erica Hanson, PharmD– PGY1 – U of M – Cash Wise Clinic Pharmacy / Carris Health
Rachel Propst, PharmD – PGY1 – CentraCare - St. Cloud Hospital
Alyssa Boesche, PharmD – PGY1 – CentraCare - St. Cloud Hospital

Objectives:  
• Discuss the evidence available regarding effectiveness and safety of DOACs for obese patient
• Evaluate the evidence and clinical use of antihistamines for G-CSF induced bone pain
• Describe the pharmacokinetics of DOACs and the evidence surrounding periprocedural bridging of these
        agents
• Identify which patients may benefit from aspirin for primary prevention based on recent guidelines and
        studies
• To evaluate evidence of use for appetite stimulation among patients without underlying disease, discuss
        risks and side effects, and discuss monitoring
• Identify when to use fidaxomicin and what evidence supports its use
• Summarize the mechanism and potential clinical use of meropenem as an antidote in valproic acid toxicity